Nature-derived psilocybin(Psyence Biomed)

N/A

Report date: 2025/09/02 17:34:44

Base Information

Drug NameNature-derived psilocybin(Psyence Biomed)
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPsyence Biomedical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPsyence Biomedical Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A